[1]
P. Kaur, D. D. Bhandari, i H. Chopra, „Streptomyces Derived Nano-doxorubicin: Clinical Status and Patents Granted“, Scr Med, vol 55, izd. 6, str. 773–784, Dec. 2024, doi: 10.5937/scriptamed55-52207.